Additionally, tirzepatide, a novel GLP-1/GIP co-agonist, has received approval for managing type 2 diabetes mellitus and is showing promising tirzepatide weight loss results, signifying a potential paradigm shift in weight loss strategies [1]
Tesamorelin is a prescription medication (FDA-approved as Egrifta) for HIV-related lipodystrophy
Strive Pharmacy Licensed Healthcare Practitioners 1,000+ physician-grade products, bulk-tier pricing, and direct shipping to your practice
The Experience & Results Your wellness journey with us is always calm, comfortable, and personalized
Initially crafted for diabetes management, this drug has revealed an impressive potential in weight management, too